SID Venture Partners

VC Kyiv · Founded 2021

SID Venture Partners targets early-stage technology startups in Central and Eastern Europe and globally, leveraging the engineering firepower and business development resources of leading software development companies to fuel product growth.

About SID Venture Partners

SID Venture Partners is a small early-stage venture firm with limited public detail on fund size, stage discipline, and category specialty. The name and positioning suggest a generalist orientation with a possible regional or sector-specific tilt that founders should validate directly during initial diligence. Treat the firm as a pre-seed and seed participant writing checks plausibly in the $100k to $750k range, typically alongside a clear lead rather than as a round-defining anchor. Healthcare exposure is opportunistic at best, with no declared specialization. Physician founders building software-shape companies with strong commercial signal may find an audience for syndicate participation, but founders building therapeutics, devices, or anything requiring deep healthcare network value should pitch a dedicated fund. Geographic posture is most likely US-broad. The realistic entry path is a warm introduction from an existing portfolio founder or a connected angel; cold outreach via LinkedIn or web form is read but conversion rates without prior connection are typically low. Founders should ask explicitly about reserves, follow-on capacity, fund vintage, and recent deal pace before assuming the firm can support beyond a first check. Treat SID Venture Partners as a syndicate slot rather than a category lead, and ensure the round dynamics, valuation, and reserves are anchored by a more specialized partner before signing.

Founder reviews

No founder reviews yet. Raised from this fund? Share your experience with other founders.

Healthcare AI tools backed by SID Venture Partners

Tools made by companies in SID Venture Partners's portfolio that we cover in the directory.

Altris AI
Altris AI
Ophthalmology AI
Altris AI is an FDA-cleared, AI-powered cloud platform for automated OCT scan analysis, detecting over 70 retinal pathologies and 40+ biomarkers. It supports ophthalmologists, optometrists, and pharma with vendor-neutral data management, quantitative progression tracking, and research-ready data export.

Portfolio companies in our directory

Other portfolio companies

Companies in SID Venture Partners's portfolio not currently in our directory.

Team

Dmytro Vartanian
Managing General Partner
LinkedIn
Valery Krasovsky
General Partner
LinkedIn

Pitch / review this investor

Have you raised from SID Venture Partners? Founders only — share your honest experience (anonymous OK, moderated before publishing).

Share your experience
Last updated 2026-05-06. Sourced from this fund's published materials.
AI Tool Finder
AI-powered search. Results may not be comprehensive.